BALTIMORE (WJZ) — A Florida-based drug maker is facing charges of price-gouging after hiking the price of a potentially life-saving cancer treatmentby 1,400 percent since 2013.
The 40-year-old medication, known as lomustine, has been used by patientssuffering from brain tumors and Hodgkin’s lymphoma. In 2013, the drug was reportedly sold to startup company NextSource. Prior to the sale, pharmaceutical giant Bristol-Myers Squibb sold the medicine for $50 per pill. Since NextSource acquired the drug, it has raised the price nine times and is now selling lomustine for a staggering $768 per pill.
The main cost of drugs is R&D not production. After 40+ years I think they know how to make it. Just crooks being crooks I guess.
ReplyDeleteyet narcan is free. sure, makes sense that junkies have better treatment then innocent people with cancer
ReplyDelete2:20 So true and so sad.
DeleteAmen to that!
DeleteThe R&D for this drug was done decades ago. It's now a cash cow.
ReplyDeleteGreed !
ReplyDelete